BNS Evening Lecture “Targeted Alpha Therapy with Astatine-211”

23 March 2023, 6:30 – 7:45 pm CET, Online

Register here:


The Belgian Nuclear Society (BNS, ENS Member Society) invites you to the new Evening Lecture “Targeted Alpha Therapy with Astatine-211”, on Thursday, 23 March. Participation in the videoconference is open and free of charge, but registration is mandatory.


Targeted Alpha Therapy (TAT) has the potential to become a curative and less toxic alternative and/or compliment to today’s standard cancer treatment. The method, which incorporates alpha-emitting radionuclides, such as At-211, coupled to cancer-targeting biological molecules like antibodies, peptides, or small molecules, can eliminate cancer cells in tumours and metastases, without causing significant damage to a patient’s healthy cells or tissues.

The lecture will be split into two parts; the first part on the scientific aspects of TAT will be given by Emma Aneheim, and the second part, which will be focused on Atley and the commercial aspects, will be led by Milton Lönnroth.

Further details are available here: